Skip to Main Content
Skip Nav Destination

SOX17 Mediates Immune Evasion During Early Colon Cancer Progression Available to Purchase

March 8, 2024

Major Finding: Early stage colorectal adenomas and cancers upregulate SOX17 to escape immune surveillance.

Concept: SOX17 suppresses sensitivity to IFNγ signaling and inhibits immunogenicity and antigen presentation.

Impact: These data suggest that restoring IFNγ responses may strengthen immune-mediated tumor clearance.

You do not currently have access to this content.
Don't already have an account? Register

Purchased this content as a guest? Enter your email address to restore access.

Please enter valid email address.

or Create an Account

Close Modal
Close Modal